The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression

OBJECTIVE: To examine the associations between pharmaceutically treated anxiety and depression and incident cardiovascular disease (CVD) among 1‐year prostate cancer survivors. PATIENTS AND METHODS: A registry‐based cohort study design was used to describe the risk of incident CVD in adult 1‐year pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollersheim, Barbara M., Boekhout, Annelies H., van der Poel, Henk G., van de Poll‐Franse, Lonneke V., Schoormans, Dounya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065160/
https://www.ncbi.nlm.nih.gov/pubmed/31773851
http://dx.doi.org/10.1111/bju.14961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065160/
https://www.ncbi.nlm.nih.gov/pubmed/31773851
http://dx.doi.org/10.1111/bju.14961

Ejemplares similares